Proteomics analysis identifies potential drug targets for aggressive human cancers
Researchers identified proteomic signatures associated with clinical measures of aggressive disease for each of the seven cancer types studied.
Read moreResearchers identified proteomic signatures associated with clinical measures of aggressive disease for each of the seven cancer types studied.
Read moreWhat is transparent, as long as a credit card is thick and helps solve science mysteries? The laboratory worm, C. elegans.
Read moreDr. Debra Murray shared her professional journey, from conducting basic science research to developing and managing programs to interest minority students in genomics.
Read moreDr. Darius Dawson shared his dedication to improving the health of minority populations, a hint to his artistic side and much more.
Read moreDr. Kathryn Jones shared how she discovered her vocation, how she unwinds at the end of the day and much more.
Read moreInhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.
Read moreBy taking a close look inside mesothelioma, Dr. B. Burt searches for clues to predict patient’s response to immunotherapy.
Read moreVariation of human immune response to RSV reinfection suggests it is important to consider this variation in vaccine design.
Read moreDr. Sillitoe shared his approach of ‘mixing the sciences’ to unravel the causes of brain diseases and something few people know about him.
Read moreIntegrating proteogenomics data of squamous cell carcinoma provides insights into genomic defects with implications for potential treatments.
Read more